Louria Hayon Igal has filed 4 insider transactions across 1 company since August 2023.
Most recent transaction: a transaction of 350000 shares of Raphael Pharmaceutical Inc. ($RAPH) on November 20, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 20, 2025 | Raphael Pharmaceutical Inc. | $RAPH | Louria Hayon Igal | Chief Technology Officer | X | Common Stock | 350000 | $0.01 | 1,349,000.0000 | 19,626,418 | 35.04% | 1.78% |
| Nov. 20, 2025 | Raphael Pharmaceutical Inc. | $RAPH | Louria Hayon Igal | Chief Technology Officer | X | Warrants to purchase Common Stock | 350000 | $0.00 | 0.0000 | 19,626,418 | 100.00% | 1.78% |
| Aug. 29, 2023 | Raphael Pharmaceutical Inc. | $RAPH | Louria Hayon Igal | Chief Technology Officer | X | Common Stock | 999000 | $0.01 | 999,000.0000 | 16,109,514 | 9999.99% | 6.20% |
| Aug. 29, 2023 | Raphael Pharmaceutical Inc. | $RAPH | Louria Hayon Igal | Chief Technology Officer | X | Warrants to purchase Common Stock | 999000 | $0.00 | 0.0000 | 16,109,514 | 100.00% | 6.20% |